Prednisolone reduces nitric oxide-induced migraine

European Journal of Neurology

Volumn 16, Issue 10, 2009, Pages 1106-1111

  Tfelt Hansen, P ^a,b   Daugaard, D ^a   Lassen, L H ^a   Iversen, H K ^a   Olesen, J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

COX 2; Glyceryl trinitrate; Migraine; Nitric oxide synthase; Prednisolone

Indexed keywords

GLYCERYL TRINITRATE; PLACEBO; PREDNISOLONE;

ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HEADACHE; HUMAN; MIDDLE CEREBRAL ARTERY; MIGRAINE; PRIORITY JOURNAL; RADIAL ARTERY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SUPERFICIAL TEMPORAL ARTERY;

ADULT; ANALYSIS OF VARIANCE; BLOOD FLOW VELOCITY; CEREBROVASCULAR CIRCULATION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE WITHOUT AURA; NITROGLYCERIN; PAIN MEASUREMENT; PREDNISOLONE; SEVERITY OF ILLNESS INDEX;

EID: 70349243405     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02654.x     Document Type: Article

References (31)

1. Olesen J, Iversen HK, Thomsen LL. Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport 1993 4 : 1027 1030. (Pubitemid 23242637)
2. Olesen J, Thomsen LL, Iversen H. Nitric oxide is a key molecule in migraine and other vascular headache. Trends Pharmacol Sci 1994 15 : 149 153.
3. Thomsen LL, Kruuse C, Iversen HK, Olesen J. A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol 1994 1 : 73 80.
4. Lassen LH, Ashina M, Christiansen I, Ulrich V, Olesen J. Nitric oxide synthase inhibition in migraine. Lancet 1997 349 : 401 402. (Pubitemid 27077677)
5. Reuter U, Bolay H, Jansen-Olesen I, et al. Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain 2001 124 : 2490 2502.
6. Newton R. Molecular mechanisms of glucocorticoid action: what is important? Thorax 2000 55 : 603 613.
7. Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (London) 1998 94 : 557 572.
8. Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibits the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A 1990 87 : 10043 10047.
9. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgia and facial pain, 2nd edn. Cephalalgia 2004 24 (Suppl. 1 1 164.
10. Russell MB, Rasmussen BK, Brennum J, Iversen HK, Jensen RA, Olesen J. Presentation of a new instrument: the diagnostic headache dairy. Cephalalgia 1992 12 : 369 374.
11. Thomsen LL, Iversen HK, Brinck TA, Olesen J. Arterial supersensivity to nitric oxide (nitroglycerin) in migraine sufferers. Cephalalgia 1993 13 : 395 399.
12. Nielsen TH, Iversen HK, Tfelt-Hansen P. Determination of the luminal diameter of the radial artery in man by high frequency ultrasound: a methodological study. Ultrasound Med Biol 1990 16 : 787 791.
13. Afridi SK, Kaube H, Goadsby PJ. Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain 2004 110 : 675 680.
14. Afridi SK, Matharu MS, Lee L, et al. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain 2005 128 : 932 939.
15. Schoonman GG, van der Grond J, Kortmann C, van der Geest RJ, Terwindt GM, Ferrari MD. Migraine headache is not associated with cerebral or meningeal vasodilatation- a 3T magnetic resonance angiography study. Brain 2008 131 : 2192 2200.
16. Iversen HK, Olesen J. Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for the development of migraine drugs. Cephalalgia 1996 16 : 412 418.
17. Akerman S, Williamson DJ, Kaube H, Goadsby PJ. Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels. Br J Pharmacol 2002 137 : 62 68.
18. Kirsten R, Nelson K, Kirsten D, Heintz B. Clinical pharmacokinetics of vasodilators. Part II. Clin Pharmacokinet 1998 35 : 9 36.
19. Croxtall JD, van Hal PTW, Choudbury Q, Gilroy DW, Flower RT. Different glucocorticoids varies in their genomic and non-genomic mechanism of action in A549 cells. Br J Pharmacol 2002 135 : 511 519.
20. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A 1993 90 : 7240 7244.
21. Høye K, Laurijsens BE, Harnisch LO, et al. Efficacy and tolerability of the iNOS inhibitor GW274150 administered up to 120 mg daily for 12 weeks in the prophylactic treatment of migraine. Cephalalgia 2009 29 : 132.
22. Pardutz A, Krizbal I, Multon S, Vecsei L, Schoenen J. Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleues caudalis. Neuroreport 2000 14 : 3071 3075.
23. Pardutz A, Szatmari E, Vecsei L, Schoenen J. Nitroglycerin-induced nNOS increase in rat trigeminal nucleus caudalis is inhibited by systemic administration of lysine acetylsalicylate but not of sumatriptan. Cephalalgia 2004 24 : 439 445.
24. Varga H, Pardutz A, Vamos E, et al. COX-2 inhibitor attenuate NO-induced nNOS in rat trigeminal nucleus. Headache 2007 47 : 1319 1325.
25. Evers S, Mylecharane EJ. Nonsteroidal anti-inflammatory and miscellaneous drugs in migraine prophylaxis. In : Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, eds. The Headaches. 3rd edn. Philadelphia : Lippincott Williams & Wilkins 2006 : 553 566.
26. Tfelt-Hansen P, Rolan P. Nonsteroidal antiinflammatory drugs in the acute treatment of migraine. In : Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, eds. The Headaches. 3rd edn. Philadelphia : Lippincott Williams & Wilkins 2006 : 449 457.
27. Lampl C, Voelker M, Diener HC. Efficacy and safety of 1000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms. J Neurol 2007 254 : 705 712.
28. Brandes JL, Kudrow D, Stark SR, et al. Sumatriptan-naproxen for acute treatment of migraine. JAMA 2007 297 : 1443 1454.
29. Di Monda V, Nicolodi M, Aloisio A, et al. Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial. Headache 2003 43 : 835 844.
30. Saper J, Dahlöf C, So Y, et al. Rofecoxib in the acute treatment of migraine: a randomised controlled clinical trial. Headache 2006 46 : 264 275.
31. Costa A, Sances G, Bagetta G, Martignon E, Tassorelli C, Nappi G. The effect of indomethacin on nitroglycerin-induced headache suggest an indirect role for nitric oxide in migraine. Cephalalgia 1997 17 : 1251.